Artelo Biosciences Inc. (NASDAQ: ARTL) started the day on February 22, 2021, with a price decrease of -7.11% at $2.22. During the day, the stock rose to $2.4673 and sunk to $2.20 before settling in for the price of $2.39 at the close. Taking a more long-term approach, ARTL posted a 52-week range of $0.45-$3.67.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -25.60%. This publicly-traded company’s shares outstanding now amounts to $15.71 million, simultaneously with a float of $13.49 million. The organization now has a market capitalization sitting at $37.52 million. At the time of writing, stock’s 50-day Moving Average stood at $1.13, while the 200-day Moving Average is $1.02.
Artelo Biosciences Inc. (ARTL) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Artelo Biosciences Inc.’s current insider ownership accounts for 7.82%, in contrast to 18.00% institutional ownership.
Artelo Biosciences Inc. (ARTL) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 11/29/2020, the organization reported -$0.14 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.1) by -$0.04. This company achieved a return on equity of -99.72. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
Artelo Biosciences Inc.’s EPS decrease for this current 12-month fiscal period is -25.60% and is forecasted to reach -0.40 in the upcoming year.
Artelo Biosciences Inc. (NASDAQ: ARTL) Trading Performance Indicators
Let’s observe the current performance indicators for Artelo Biosciences Inc. (ARTL). It’s Quick Ratio in the last reported quarter now stands at 15.40. The Stock has managed to achieve an average true range (ATR) of 0.36.
In the same vein, ARTL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.04, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.40 at the market close of one year from today.
Technical Analysis of Artelo Biosciences Inc. (ARTL)
If we take a close look at the recent performances of Artelo Biosciences Inc. (NASDAQ: ARTL), its last 5-days Average volume was 9.67 million that shows plunge from its year to date volume of 15.07 million. During the previous 9 days, stock’s Stochastic %D was recorded 47.75% While, its Average True Range was 0.42.
Raw Stochastic average of Artelo Biosciences Inc. (ARTL) in the period of the previous 100 days is set at 54.95%, which indicates a major rise in contrast to 42.46% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 257.42% that was higher than 137.92% volatility it exhibited in the past 100-days period.